
https://www.science.org/content/blog-post/worst-seminar
# The Worst Seminar (September 2014)

## 1. SUMMARY

This article recounts a personal anecdote from the author's graduate school days about attending an exceptionally poor seminar. The author describes sitting through a "deadly talk" delivered in a "nasal monotone" at "dictation speed" with uninteresting content. After the seminar, the author's labmate loudly proclaimed it "the WORST seminar I have EVER heard in my LIFE," only to realize the seminar speaker had just walked by and overheard the comment. The article is framed as a humorous reflection on terrible academic presentations, with the author inviting readers to share their own worst seminar experiences in the comments. The piece also includes a technical aside about searching the author's website using Google's site-specific search functionality.

## 2. HISTORY

This article was published on Derek Lowe's "In the Pipeline" blog, which has been a long-running commentary site about the pharmaceutical and biotechnology industry. Since 2014, the blog has continued under various platforms, with Lowe remaining one of the most respected and widely-read voices in pharmaceutical chemistry commentary.

In the years following this post, the "In the Pipeline" blog has maintained its reputation for candid, expert analysis of drug discovery and pharmaceutical industry developments. The blog format itself has largely remained a platform for scientific professionals to share insights, though the landscape of scientific communication has evolved with the rise of social media platforms like Twitter for scientific discourse and the continued growth of preprint servers like bioRxiv.

The specific content of this post—a lighthearted anecdote about academic seminars—reflects the personal, narrative style that has characterized much of Lowe's writing and helped maintain reader engagement over decades. Scientific seminars and conferences have continued as essential parts of academic and industry culture, with virtual formats becoming more common after 2020.

## 3. PREDICTIONS

• **No scientific or industry predictions**: This article contains no predictions about biotechnology, pharmaceutical development, or scientific trends. It is purely anecdotal and retrospective rather than predictive.

## 4. INTEREST

Rating: **2/10**

This personal anecdote about a poor seminar experience has minimal relevance to biotechnology industry developments or scientific analysis, serving more as light commentary on academic culture rather than substantive industry content.

---

*Note: This article does not discuss biotechnology topics with analyzable scientific or commercial implications. The "Worst Seminar" refers to presentation quality, not biotech research outcomes, so there are no drug approvals, clinical trials, or policy developments to evaluate from this content.*


----
_model_params = {'model': 'nex-agi/deepseek-v3.1-nex-n1:free', 'input': '20140918-worst-seminar.txt', 'reasoning': {'effort': 'high'}, 'text': {'verbosity': 'medium'}, 'prompt-template': 'prompt-template-2'}_